The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why BYAH Stock advanced +1.71% Today — RQD Quant Desk Flash
Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) carries a Roarable Rating of D+ (Sell) with 57/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 3.4% FCF Margin ($85.9K FCF) & 94.4% Gross Margin
FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 42.3 (NEUTRAL RANGE)
Dilution Drag (+1.36% YoY Shares) & executive Form 4 sales trim 13 pts from alignment
⚔️ Adversarial Opposing Case: Why the BYAH Bull Thesis Could Fail
Even with a 57/100 (D+) score, BYAH faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Company executives have done more routine share selling than personal cash buying lately.
Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($2.49) or 200D SMA ($10.86) invalidates the momentum regime and cuts Target Base ($2.29) toward Bear Floor ($1.79).
Why BYAH Stock advanced +1.71% Today — RQD Quant Desk Flash
Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) advanced +1.71% to $2.30, trading at 2% of its 52-week range ($1.9 – $158). Stretched risk/reward at current multiples (94% profit margin) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.9 – $158) with RSI-14 at 42.3 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.30 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 94.4% gross margin and $85852 annual free cash flow.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
German ministers pledge tough action after rioters damage stores in Frankfurt Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BYAH)
- ✓Walkthrough of BYAH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
BYAH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on BYAH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for BYAH. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BYAH)
1. Head-to-Head Consumer Discretionary Peer Comparison (BYAH vs. BNKK, CABR, YCBD, UG)
Industry: Package Goods/Cosmetics (23 Tracked Issuers)Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) ranks #491 by composite RQD confidence (57/100, grade D+) and #945 by equity capitalization ($7.9M). Within this direct 5-issuer industry benchmark cohort, UG leads on earnings valuation at 14.5x trailing P/E, while UG leads on capital efficiency and profitability with 17.8% ROIC and — gross margin. UG currently holds the highest overall quantitative score in the immediate peer group at 70/100 (B-) compared with BYAH at 57/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BYAH
ACTIVE
Park Ha Biological Technology Co. Ltd. (Class A) | D+ | 57/100 | — | 94.4% | — | +1.71% | $7.9M | Benchmark Subject |
| BNKK Bonk Inc. | D | 45/100 | — | 58.5% | -35.0% | -2.48% | $9.4M | /bnkk-vs-byah → |
| CABR Caring Brands Inc. | D- | 38/100 | — | 55.6% | -35.0% | -4.46% | $11.2M | /cabr-vs-byah → |
| YCBD cbdMD Inc. | D- | 43/100 | — | 62.4% | -30.4% | +4.56% | $4.3M | /ycbd-vs-byah → |
| UG United-Guardian Inc. | B- | 70/100 | 14.5x | — | 17.8% | -1.19% | $30.6M | /ug-vs-byah → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-10-31 • CIK 0001986247In its most recent audited fiscal period (FY2025, filed 2025-10-31), Park Ha Biological Technology Co. Ltd. (Class A) (BYAH) reported GAAP revenue of $2.5M (+6.0% vs. FY2024 revenue of $2.4M , and +2.7% cumulative change since FY2023) , GAAP net income of -$24.4M, operating cash flow of $85.9K, and free cash flow of $85.9K (-91.1% YoY). On the balance sheet, BYAH closed FY2025 with $6.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-10-31 | $2.5M | -$24.4M | $85.9K | $85.9K | $6.0M | — |
| FY2024 (FY) | 2024-10-31 | $2.4M | $478.6K | $960.5K | $960.5K | — | — |
| FY2023 (FY) | 2023-10-31 | $2.5M | $852.0K | $126.5K | $126.5K | — | — |
3. BYAH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BYAH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Park Ha Biological Technology Co. Ltd. (Class A) (NASDAQ: BYAH) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 57/100 at a spot price of $2.30 (+1.71% 1D, market cap $7.9M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 7/20. Across 1011 tracked Consumer Discretionary issuers, BYAH ranks #491 in composite RQD confidence.
How does BYAH compare to BNKK and CABR in the Consumer Discretionary sector?
Within the Consumer Discretionary sector (Package Goods/Cosmetics), BYAH carries a Roarable D+ (57/100 RQD), trailing P/E of N/A, gross margin of 94.4%, and ROIC of —. By comparison, BNKK (Bonk Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC -35.0%, cap $9.4M) and CABR (Caring Brands Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $11.2M). Among the 5-stock peer group, UG leads on earnings multiple (14.5x) while UG leads on capital efficiency (17.8% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BYAH?
Per BYAH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-10-31, CIK 0001986247), Park Ha Biological Technology Co. Ltd. (Class A) generated $2.5M in revenue (+6.0% YoY), -$24.4M in net income, and $85.9K in free cash flow against $6.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BYAH trading relative to its 50-day, 200-day, and 52-week technical levels?
BYAH last traded at $2.30 (+1.71% on volume of 2,204 shares), positioning the stock -7.63% below its 50-day simple moving average ($2.49) and -78.82% below its 200-day simple moving average ($10.86). Across its 52-week range of $1.90 to $158.00, BYAH sits at the 0.3% percentile with a 14-day RSI of 42.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.01 to $2.59).
BYAH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BYAH stock moving today?
Why BYAH Stock advanced +1.71% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (94% profit margin) under elevated 10-year interest-rate pressure.